Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely
M L
ML
Division of Organ Transplantation, Harvard Medical School, New England Deaconess Hospital, Boston, Massachusetts 02215.
Shaffer
D
D
Ohzato
H
H
Gottschalk
R
R
Van der Werf
W J
WJ
Monaco
A P
AP
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006085:Graft Survival / Q000276:immunology*; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control; D007165:Immunosuppression Therapy / Q000379:methods*; D007421:Intestine, Small / Q000637:transplantation*; D017710:Lymphocyte Transfusion; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013154:Spleen / Q000276:immunology; D013950:Thymus Gland; D013997:Time Factors; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000961:Antilymphocyte Serum